The ADGRL4 gene helps guide how blood vessels grow and how the cells lining them communicate. This gene plays an important role in building and maintaining a healthy blood supply during growth and tissue repair. If the gene does not work properly, blood vessel formation and cell signaling may become less controlled, which can affect how tissues get oxygen and nutrients. Researchers also study the ADGRL4 gene in cancer because tumors may use these vessel growth signals.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the working parts of cells. Others mainly guide when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
ADGRL4Gene function
What if the gene works
The ADGRL4 gene helps cells that line blood vessels communicate during vessel growth. It supports the formation and remodeling of blood vessels in developing and adult tissues.
Risk
What if the gene does not work
Changes in the ADGRL4 gene can range from milder to more severe variants. These changes may alter how this cell surface receptor helps endothelial cells sense signals and organize blood vessel growth, affecting how strongly the protein works.
Treatment
What does that mean for your treatment
No treatment or management approach specifically tied to pathogenic variants in the ADGRL4 gene is currently established. The ADGRL4 gene is being studied as a marker and possible drug target in tumor blood vessel growth, especially in cancers such as glioblastoma, but this has not led to guideline-based treatment choices.
Gene function
What if the gene works
Your blood vessels rely on the ADGRL4 gene to help vessel lining cells grow and organize in a controlled way. It is most active during blood vessel growth and remodeling, including when new vessels are forming. This supports a steady blood supply to tissues throughout the body.
The ADGRL4 gene helps make a receptor on the surface of blood vessel lining cells. This receptor allows the cells to sense signals from nearby cells and the surrounding tissue.
This gene supports angiogenesis (the growth of new blood vessels). It helps vessel lining cells multiply and move in a coordinated way as small branches begin to form.
Proper ADGRL4 activity helps developing vessels arrange into an organized network. This shaping process supports steady blood flow as tissues grow and renew themselves.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the body’s response to environmental influences. A large number of variants cause no noticeable effects and are simply part of natural genetic variation. At times, though, a variant can change gene function more markedly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the ADGRL4 gene can alter how the receptor protein folds, reaches the cell surface, and passes signals between nearby cells. In understanding how ADGRL4 gene variants affect cell signaling, milder changes may only weaken protein stability or partner binding, while more disruptive variants can shorten the receptor or keep it from being placed correctly in the cell membrane. This usually leads to reduced or lost signaling activity.
How variants are linked to conditions
Variants in the ADGRL4 gene do not yet have a broadly confirmed link to a specific health condition, although research on ADGRL4 gene variants and health conditions is still developing. If you carry a reported change in this gene, your doctor or genetic counselor can interpret it in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ADGRL4 gene. People who have questions about their personal or family risk can talk with a doctor or genetic counselor.
Inheritance of ADGRL4 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the ADGRL4 gene, so ADGRL4 gene inheritance is not defined in the same clear way as for classic dominant or recessive genetic conditions. As research develops, this picture may become clearer for particular health effects. The ADGRL4 gene is located on chromosome 1, which is an autosome, so each person inherits one copy from each parent.
What does my ADGRL4 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for ADGRL4. If you have an ADGRL4 result and want to understand what it could mean for parents, children, brothers, sisters, or other relatives, a doctor or genetic counselor can explain it in the context of your exact result and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry an ADGRL4 variant, ADGRL4 genetic testing uses a blood sample, saliva, or a cheek swab to read the DNA sequence in this gene. A lab compares your result with the usual sequence and reports whether a variant was found, often as part of a multigene panel, exome, or genome test.
When should I consider getting a genetic test?
There is not yet a broadly established, ADGRL4-specific medical reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, family history, and whether a doctor or genetic counselor thinks a broader gene panel could be helpful.
A genetic result is only one part of your health story
A genetic result can provide valuable information, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help place personal experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication works well for one person, seems weaker in another, or causes more side effects in someone else. These differences are common and can influence both how effective a treatment feels and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene-drug patterns to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can help support treatment decisions that are more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the ADGRL4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. Questions about side effects, how well a treatment is working, or concerns about medicines are best discussed with your doctor.
History
The ADGRL4 gene was first described in the early 2000s, when researchers were mapping newly identified cell surface receptors and sorting them into growing gene families. It was initially reported under the name ELTD1, reflecting how scientists classified it at the time. As medical science evolved, so did understanding of this gene, and later naming systems placed it in the latrophilin branch of the adhesion G protein coupled receptor family, leading to the current name, the ADGRL4 gene. This renaming was part of a broader effort to make gene names more consistent across research and clinical genetics. Over time, descriptions became more precise, and the ADGRL4 gene found a clearer place in modern human genetics.